These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 31978901)

  • 21. Comparison of the radiomics-based predictive models using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma.
    Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
    Phys Eng Sci Med; 2023 Mar; 46(1):395-403. PubMed ID: 36787023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
    AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
    Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
    Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
    Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.
    Jiang M; Zhang Y; Xu J; Ji M; Guo Y; Guo Y; Xiao J; Yao X; Shi H; Zeng M
    Nucl Med Commun; 2019 Aug; 40(8):842-849. PubMed ID: 31290849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
    Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
    Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer.
    Dang Y; Wang R; Qian K; Lu J; Zhang H; Zhang Y
    J Appl Clin Med Phys; 2021 Jan; 22(1):271-280. PubMed ID: 33314737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
    Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
    Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
    Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
    Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study.
    Wu J; Meng H; Zhou L; Wang M; Jin S; Ji H; Liu B; Jin P; Du C
    Sci Rep; 2024 Jul; 14(1):15877. PubMed ID: 38982267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
    Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
    Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2D and 3D texture analysis to predict lymphovascular invasion in lung adenocarcinoma.
    Yang G; Nie P; Zhao L; Guo J; Xue W; Yan L; Cui J; Wang Z
    Eur J Radiol; 2020 Aug; 129():109111. PubMed ID: 32559593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
    Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
    Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Interval Growth of Lung Adenocarcinomas Manifesting as Persistent Subsolid Nodules ≤3 cm Based on Radiomic Features.
    Wu FZ; Wu YJ; Chen CS; Tang EK
    Acad Radiol; 2023 Dec; 30(12):2856-2869. PubMed ID: 37080884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
    Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
    J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
    Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
    Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
    Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
    Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
    Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
    Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
    Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
    Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.